» Articles » PMID: 28606921

Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2017 Jun 14
PMID 28606921
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Investigate the role of regulator of chromosome condensation 2 () on lung adenocarcinoma (LUAD) metastasis. Clinical specimens were used to assess the impact of RCC2 on LUAD metastasis. Mouse models, cytobiology, and molecular biology assays were performed to elucidate the function and underlying mechanisms of RCC2 in LUAD. RCC2 expression was frequently increased in LUADs (88/122, 72.13%). It was confirmed by analysis of a larger cohort of TCGA RNA-seq data containing 488 LUADs and 58 normal lung tissues ( < 0.001). Importantly, increased level of RCC2 was significantly associated with T status of tumor ( = 0.002), lymph node metastasis ( = 0.004), and advanced clinical stage ( = 0.001). Patients with LUAD with higher expression of RCC2 had shorter overall survival. Cox regression analysis demonstrated that RCC2 was an independent poorer prognostic factor for patients with LUAD. Moreover, forced expression of RCC2 promoted intrapulmonary metastasis and significantly enhanced LUAD cell migration, invasion, and proliferation Further study found that RCC2 induced epithelial-mesenchymal transition (EMT) and also stimulated the expression of MMP-2 and MMP-9. In addition, RCC2 was able to activate JNK, while inhibition of JNK suppressed the effect of RCC2 on LUAD cell migration, invasion, EMT, and the expression of MMP-2 and MMP-9. RCC2 plays a pivotal role in LUAD metastasis by inducing EMT via activation of MAPK-JNK signaling. .

Citing Articles

Inhibition of glutathione peroxidase 4 suppresses gastric cancer peritoneal metastasis via regulation of RCC2 homeostasis.

Hu C, Xu J, Zhang Y, Zhang R, Pan S, Chen J Redox Biol. 2025; 80:103519.

PMID: 39908861 PMC: 11847474. DOI: 10.1016/j.redox.2025.103519.


Significance of RCC2, Rac1 and p53 Expression in Breast Infiltrating Ductal Carcinoma; An Immunohistochemical Study.

Hemida A, Abdelaziz R, Abd El-Wahed M, Asaad N, Serag El-Dien M, Elshahat Ali H Iran J Pathol. 2024; 19(2):177-192.

PMID: 39118792 PMC: 11304461. DOI: 10.30699/IJP.2024.2014367.3198.


circRNA-0015004 act as a ceRNA to promote RCC2 expression in hepatocellular carcinoma.

Zhao J, Zhang T, Wu P, Qiu J, Wu K, Shi L Sci Rep. 2024; 14(1):16913.

PMID: 39043840 PMC: 11266727. DOI: 10.1038/s41598-024-67819-8.


PTBP1-mediated biogenesis of circATIC promotes progression and cisplatin resistance of bladder cancer.

Huang C, Yang Y, Wang X, Chen S, Liu Z, Li Z Int J Biol Sci. 2024; 20(9):3570-3589.

PMID: 38993556 PMC: 11234215. DOI: 10.7150/ijbs.96671.


Genome-Wide Methylation Analysis in Two Wild-Type Non-Small Cell Lung Cancer Subgroups with Negative and High PD-L1 Expression.

Hutarew G, Alinger-Scharinger B, Sotlar K, Kraus T Cancers (Basel). 2024; 16(10).

PMID: 38791918 PMC: 11119885. DOI: 10.3390/cancers16101841.